Predictive Oncology Inc. - COM (POAI)

CUSIP: 74039M309

Q2 2023 13F Holders as of 30 Jun 2023

Share change
+231,783
SEC-reported price per share
$4.86
Number of holders
11
Value change
+$1,126,727
Number of buys
11

Security key

74039M309

Report period

Q2 2023

Institutions

11

Top holders

10

Ownership snapshot

Top reported holders of POAI - Predictive Oncology Inc. - COM (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
J. Melville Engle
Disclosed value leader
J. Melville Engle
Comparable rows
0/4
Latest evidence
03 Apr 2023
3/4/5 Highest disclosed value: $1,233,411 4 rows are not safely comparable across share classes.

Quick read

J. Melville Engle has the largest disclosed position value at $1.23M.

0 of 4 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens J. Melville Engle's linked filing trail.
Disclosed position value Top 4
J. Melville Engle $1.23M
David Stewart Smith $322.7K
Christina L. Jenkins MD $213.1K
Pamela Bush $140.2K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-4 of 4 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
J. Melville Engle
3/4/5
FORMER CEO AND FORMER DIRECTOR
class O/S missing
$1,233,411
416,693 shares
01 Nov 2022
David Stewart Smith
3/4/5
Director
class O/S missing
$322,717
109,026 shares
03 Apr 2023
Christina L. Jenkins MD
3/4/5
Director
class O/S missing
$213,082
71,987 shares
01 Jul 2022
Pamela Bush
3/4/5
Chief Business Officer
class O/S missing
$140,224
47,373 shares
31 Jan 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
11
Shares
231,783
Rows available
11
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2023 vs Q3 2025 Across Filers

Q3 2025 holders
2
Q2 2023 holders
11
Holder diff
9
Investor Q3 2025 Shares Q2 2023 Shares Share Diff Share Chg % Q3 2025 value Q2 2023 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .